戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 antly potentiated by substrate inhibition of adenosine kinase.
2 nterplay between nucleoside transporters and adenosine kinase.
3 ansporter and is a substrate of T. b. brucei adenosine kinase.
4  intractable epilepsy demonstrated increased adenosine kinase.
5  excellent subversive substrate of T. gondii adenosine kinase.
6 f BTI as subversive substrates for T. gondii adenosine kinase.
7                                          The adenosine kinase activity in dorsal root ganglion cultur
8                Furthermore, an alteration of adenosine kinase activity modifies the degree of this in
9 itiation of toxicity in sympathetic neurons, adenosine kinase activity was compared in sensory and sy
10    Furthermore, both adenosine deaminase and adenosine kinase activity was significantly diminished (
11 posure to DEA/NO nearly completely inhibited adenosine kinase activity.
12 e levels with a combination of inhibitors of adenosine kinase, adenosine deaminase, and the equilibra
13 suppress local silencing by interacting with adenosine kinase (ADK) and can suppress basal defense by
14                                              Adenosine kinase (ADK) catalyzes the phosphorylation of
15                                              Adenosine kinase (ADK) deficiency in human patients (OMI
16                                              Adenosine kinase (ADK) from Mycobacterium tuberculosis (
17 M #614300) that is based on mutations in the adenosine kinase (Adk) gene has been discovered recently
18 ilencing by a mechanism that correlates with adenosine kinase (ADK) inhibition, while AL2 in addition
19                                              Adenosine kinase (AdK) inhibitors raise endogenous adeno
20                                              Adenosine kinase (ADK) is a key enzyme that regulates in
21 ntracellular adenosine and its key regulator adenosine kinase (ADK) play important roles in vascular
22 ich involves interacting with and inhibiting adenosine kinase (ADK), a cellular enzyme associated wit
23  viral proteins interact with and inactivate adenosine kinase (ADK), a cellular enzyme important for
24        Here we show that astrocyte-expressed adenosine kinase (ADK), a key negative regulator of the
25  viral proteins interact with and inactivate adenosine kinase (ADK), a nucleoside kinase that catalyz
26  of adenosine by pharmacologic inhibition of adenosine kinase (ADK), the key enzyme of adenosine clea
27      AL2 and L2 interact with and inactivate adenosine kinase (ADK), which is required for efficient
28 s shown to decrease expression of the enzyme adenosine kinase (Adk), which is responsible for clearin
29                            The regulation of adenosine kinase (AK) activity has the potential to cont
30 bercidin" analogues are potent inhibitors of adenosine kinase (AK) and are orally active in animal mo
31 -702 is a novel and selective non-nucleoside adenosine kinase (AK) inhibitor that produces increases
32 rted that analogues of tubercidin are potent adenosine kinase (AK) inhibitors with antiseizure activi
33                                              Adenosine kinase (AK) is a key enzyme in the regulation
34                                              Adenosine kinase (AK) is a key purine metabolic enzyme f
35                                              Adenosine kinase (AK) is a purine salvage enzyme that ca
36                                              Adenosine kinase (AK) is an enzyme responsible for conve
37 resistant clones exhibited disruption of the adenosine kinase (AK) locus, others displayed normal AK
38 denine phosphoribosyltransferase (APRT), and adenosine kinase (AK) to purine salvage in Leishmania do
39 ne (ADO) can be raised through inhibition of adenosine kinase (AK), a primary metabolic enzyme for AD
40 the activities of adenosine deaminase (ADA), adenosine kinase (AK), and inosine monophosphate-specifi
41 DO can be enhanced consists of inhibition of adenosine kinase (AK), the primary metabolic enzyme for
42                                Inhibition of adenosine kinase (AK), the primary metabolic enzyme for
43 anine phosphoribosyltransferase (HXGPRT) and adenosine kinase (AK).
44 ll fold is similar to that of ribokinase and adenosine kinase, although sequence similarity is not im
45 virin, and both compounds are substrates for adenosine kinase, an enzyme critical for conversion to t
46                                        Also, adenosine kinase and 60S ribosomal protein were confirme
47 dogenous adenosine produced by inhibition of adenosine kinase and adenosine deaminase.
48                                Inhibition of adenosine kinase and deoxycytidine kinase prevented the
49            8-Cl-Ado activity is dependent on adenosine kinase and requires intracellular accumulation
50                                       Unlike adenosine kinase and ribokinase, in which the active sit
51 e substrates of T. gondii,but not the human, adenosine kinase are preferentially metabolized to their
52 he (redundant) purine salvage pathway enzyme adenosine kinase are susceptible to the drug, with an IC
53 orylation of one or more proteins other than adenosine kinase as a consequence of NMDA receptor activ
54  efflux of adenosine resulting from block of adenosine kinase at only a subset of synapses.
55 the activity of both adenosine deaminase and adenosine kinase (both p </= .0001).
56                          P. falciparum lacks adenosine kinase but can salvage AMP synthesized in the
57                            The inhibition of adenosine kinase by 5-iodotubercidin increased the extra
58                We observed the repression of adenosine kinase by proinflammatory cytokines and found
59         We determined the structure of human adenosine kinase by X-ray crystallography using MAD phas
60                                              Adenosine kinase catalyzes the phosphorylation of adenos
61                                Studies in an adenosine kinase deficient cell line showed that the 6-N
62 nosine accumulates high levels of dATP in an adenosine kinase-dependent process and dies within a few
63                  We tested the expression of adenosine kinase during inflammatory stimulation in vitr
64 -monophosphate (AMP) catalyzed by the enzyme adenosine kinase (EC 2.7.1.20).
65 ized and evaluated against Toxoplasma gondii adenosine kinase (EC.2.7.1.20).
66                                Inhibitors of adenosine kinase elevate adenosine to levels that activa
67 ects of iodotubercidin (ITU, an inhibitor of adenosine kinase), erythro-9-(2-hydroxy-3-nonyl)adenine
68 ad to endothelial inflammation by increasing adenosine kinase expression, and that its knockdown in e
69 ocked with 5-iodotubercidin, an inhibitor of adenosine kinase, folate transport stimulation by AICAR
70                            The high-affinity adenosine kinase from Anopheles gambiae efficiently conv
71 osine by biallelic genetic disruption of the adenosine kinase gene (Adk-/-), and respective wild-type
72  On the basis of the evidence of the role of adenosine kinase in regulating adenosine levels during h
73                                              Adenosine kinase in T. gondii is significantly more acti
74                            The inhibition of adenosine kinase in vivo showed protective properties, r
75                           We found different adenosine kinase-inactivating (ADK-inactivating) alterat
76 ndogenous adenosine levels through selective adenosine kinase inhibition produces powerful analgesic
77 ed adenosine accumulation is associated with adenosine kinase inhibition.
78 viously has been shown to be associated with adenosine kinase inhibition.
79 phosphatase 1/2A did not abolish NMDA-evoked adenosine kinase inhibition.
80 ced by treatment of rats with ethanol and an adenosine kinase inhibitor (ABT702).
81 -deficient cultures were also rescued by the adenosine kinase inhibitor 5'-amino-5'-deoxyadenosine (5
82                                 Moreover, an adenosine kinase inhibitor 5'-iodotubercidin, which effe
83                   In contrast, the selective adenosine kinase inhibitor 5-iodotubercidin (5-IT; 10 mi
84  or inhibition of AICAR conversion to ZMP by adenosine kinase inhibitor 5-iodotubercidin.
85                           Treatment with the adenosine kinase inhibitor 5-iodotubericidin to inhibit
86 ptive effects of AMP, when combined with the adenosine kinase inhibitor 5-iodotubericidin, were reduc
87 w that 5-iodotubercidin (5-IT), an annotated adenosine kinase inhibitor previously reported to increa
88 transport blocker); and (3) iodotubericidin (adenosine kinase inhibitor).
89                                          The adenosine kinase inhibitor, 5-iodotubercidin (10 microme
90                             In contrast, the adenosine kinase inhibitor, 5-iodotubericidin, which inh
91 enzoxy-Val-Ala-Asp-fluoromethyl ketone or an adenosine kinase inhibitor, but not in cultures with fet
92 romo-pyrazolo [3,4-d] pyrimidine, a specific adenosine kinase inhibitor-as well as continuous intra-a
93  platform, we identify a class of compounds [adenosine kinase inhibitors (ADK-Is)] that promote repli
94    As an alternative, we explored the use of adenosine kinase inhibitors (AKIs) as potential antiseiz
95              We previously demonstrated that adenosine kinase inhibitors (AKIs) exhibit antiinflammat
96                                              Adenosine kinase inhibitors (AKIs) represent an alternat
97 ucleosides were synthesized and evaluated as adenosine kinase inhibitors (AKIs).
98 ido[2,3-d]pyrimidines as novel nonnucleoside adenosine kinase inhibitors is described.
99                                        Thus, adenosine kinase is a structurally distinct mammalian nu
100         Taken together, these data show that adenosine kinase is a valuable target for reducing the i
101  deaminase blockade but not when erythrocyte adenosine kinase is also inhibited.
102            It has been found previously that adenosine kinase is inhibited by its substrate, adenosin
103                                     However, adenosine kinase is not a direct substrate for phosphata
104 ibility that in our system the inhibition of adenosine kinase is related to an increase in intracellu
105                                Wild-type and adenosine kinase+/- mice were subjected to lipopolysacch
106           In vitro cell lines, wild-type and adenosine kinase+/- mice.
107 s during hypoxia, we evaluated the effect of adenosine kinase on lung injury.
108 ence of a pharmacologic approach to blocking adenosine kinase on the extent of lung injury.
109 een shown that the activity of intracellular adenosine kinase preferentially controls the activation
110                            Studies using the adenosine kinase promoter were performed in vitro.
111 er of activated B-cells on regulation of the adenosine kinase promoter.
112                         Mice with endogenous adenosine kinase repression (adenosine kinase+/-) showed
113 nd ADO1, encoding an adenylate kinase and an adenosine kinase, respectively, negatively regulate PHO5
114 with endogenous adenosine kinase repression (adenosine kinase+/-) showed reduced infiltration of leuk
115 ied and incorporated into lead inhibitors of adenosine kinase that exhibited potent in vitro and in v
116 ot analysis demonstrated that the KD reduced adenosine kinase, the major adenosine-metabolizing enzym
117 hen FTOC were performed with an inhibitor of adenosine kinase, the major thymic deoxyadenosine phosph
118 lar to that proposed for both ribokinase and adenosine kinase, ThiK lacks an absolutely conserved Asp
119                  Pharmacologic inhibition of adenosine kinase was performed in vitro, and its effect
120                                              Adenosine kinase was the major determinant of adenosine
121 th cDNA clones encoding catalytically active adenosine kinase were obtained from lymphocyte, placenta
122 ne deposition, homologous recombination, and adenosine kinase, which influences the methionine cycle.
123 n of analogues that are potent inhibitors of adenosine kinase with in vivo analgesic activity.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top